Navigation Links
Adeona Announces HartLab Expansion Into Microbiology Testing Services
Date:6/15/2010

op5='External Link';s.eVar3=s.prop5;s.prop15='96362114';s.tl(this,'o','ExternalLink');" target='_blank' href="http://www.adeonapharma.com/">www.adeonapharma.com.

This release includes forward-looking statements on Adeona's current expectations and projections about future events. In some cases forward-looking statements can be identified by terminology such as "may," "should," "potential," "continue," "expects," "anticipates," "intends," "plans," "believes," "estimates," and similar expressions. These statements are based upon current beliefs, expectations and assumptions and are subject to a number of risks and uncertainties, many of which are difficult to predict and include statements regarding additional services making HartLab more competitive and HartLab's ability to develop and implement new culture techniques, immunoassays, and molecular methods for rapid detection and identification of common as well as unusual microbial pathogens. The forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from those reflected in Adeona's forward-looking statements include, among others, a failure to expand the services currently offered or develop techniques and methods for rapid detection of microbial pathogens, a failure of additional services to result in the attraction of new customers, and other factors described in Adeona's report on Form 10-K for the year ended December 31, 2009 and any other filings with the SEC. The information in this release is provided only as of the date of this release, and Adeona undertakes no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.


'/>"/>
SOURCE Adeona Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Upsher-Smith Laboratories Announces Initiation of Phase III Clinical Trial of USL255 (Extended-Release Topiramate) for Adjunctive Treatment of Partial-Onset Epilepsy
2. Poniard Announces Final Data from Phase 3 SPEAR Trial of Picoplatin in Small Cell Lung Cancer
3. Genomic Health Announces Results From the Largest Genomic Analysis of Localized Clear Cell Renal Carcinoma at American Society of Clinical Oncology (ASCO) Annual Meeting
4. Par Pharmaceutical Announces the Resignation of Its Chief Financial Officer
5. Acuo Technologies Announces Implementation and Acceptance of Acuos DICOM Services Grid(TM) With Lancaster General Hospital
6. Perrigo Announces FDA Final Approval for Miconazole
7. Hospira Announces Further Extension of Tender Offer for Shares of Javelin Pharmaceuticals
8. Astellas Announces Successful Completion of Initial Tender Offer for Shares of OSI and Announces Subsequent Offer Period
9. GSK Announces Revised Product Labels for Serevent® and Advair®
10. US Oncology Announces iKnowMed(TM) Technology Platform
11. Orexigen® Therapeutics Announces FDA Acceptance of Contrave® New Drug Application for the Treatment of Obesity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... today announced it has established a relief fund ... that has gripped much of the nation. AARP and its ... support these emergency relief efforts AARP and AARP Foundation will ... to $500,000 in aid. The matching program will be administered ...
(Date:1/15/2014)...  Humberto C. Antunes,  Galderma  worldwide CEO, will receive a ... of Drugs in Dermatology (JDD) at the upcoming ... is January 17-20, 2014, at the Omni Orlando Resort at ChampionsGate ... The ODAC is a distinguished event that delivers a ...
(Date:1/15/2014)... 2014 MultiCell Technologies, Inc. (OTC Bulletin Board: ... application concerning composition of matter, biological targets, mechanism of ... death.  This patent application describes a ... molecules (VSRNAs) which interfere with the basic homeostatic cellular ...
Breaking Medicine Technology:AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3
... Reported at American Association for Cancer Research ... -- Favrille,Inc. , a biopharmaceutical company developing ... announced,results from a new study showing enhanced ... key component in the Company's,Id/KLH immunotherapy product ...
... Origin May Be Useful in Cancer Treatment,Decisions , ... Inc.,(NASDAQ: MYGN) (<a target="_blank" href=,"http://www.myriad.com/">www.myriad.com ) announced today ... might be used to,determine the original location of ... the annual meeting of the American Association,for Cancer ...
Cached Medicine Technology:Favrille Announces Results From Study Showing Enhanced Activity,From Insect Cell-Derived Immunotherapy for Lymphoma 2Favrille Announces Results From Study Showing Enhanced Activity,From Insect Cell-Derived Immunotherapy for Lymphoma 3Favrille Announces Results From Study Showing Enhanced Activity,From Insect Cell-Derived Immunotherapy for Lymphoma 4Myriad Genetics Presents Tumor Origin Technology at AACR 2Myriad Genetics Presents Tumor Origin Technology at AACR 3
(Date:4/17/2014)... of California, San Diego School of Medicine report that ... a recent major loss are more likely to be ... study is published in this month,s issue of the ... compassionate behaviors are associated with better health and well-being ... ways to improve the outcomes of individuals whose deficits ...
(Date:4/17/2014)... University synthetic biology team has created a new ... therapeutics that could travel the body and selectively ... Engineering cell-based, biological devices that monitor and modify ... synthetic biology. However, no existing technology enabled bioengineers ... physiological state and respond in a customized fashion. ...
(Date:4/17/2014)... 16, 2014) The cause of neuronal death in ... proposes that neurons may be mistaken for foreign invaders ... to the way autoimmune diseases like type I diabetes, ... The study was published April 16, 2014, in ... likely controversial, idea in Parkinson,s disease; but if true, ...
(Date:4/17/2014)... Alliance, a nonprofit organization that focuses on conservation and ... examining the current state of knowledge of the deadly ... global surveillance strategies to combat the emergence of infectious ... West Africa that has claimed the lives of 122 ... According to the World Health Organization (WHO), the deadly ...
(Date:4/17/2014)... 2014) Population Council scientists and their partners have found ... can prevent the transmission of multiple sexually transmitted infections ... HIV, herpes simplex virus 2 (HSV-2), and human papillomavirus ... that the gel is effective against multiple strains of ... vagina against all three viruses of at least eight ...
Breaking Medicine News(10 mins):Health News:The ilk of human kindness 2Health News:Building 'smart' cell-based therapies 2Health News:Is Parkinson's an autoimmune disease? 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 3Health News:Animal study provides first evidence that gel can prevent multiple virus transmission in vagina/rectum 2
... teenagers have a lot in common: Sugary soda. Fast-food ... Low-income teenagers are almost three times more likely to ... to new research from the UCLA Center for Health ... 21 percent of teenagers living in low-income families are ...
... Calif., Dec. 10 ThermoGenesis,Corp. (Nasdaq: KOOL ... process and store adult stem cells, said today that ... (POC) products under the,Vantus brand. Unveiling of the ... 54th Annual Convention of the American Association of Equine,Practitioners ...
... HONOLULU, Dec. 10 Hoana Medical announced today that ... at the Institute for Healthcare Improvement (IHI) premier event ... leaders in hospital,safety. , ... conjunction with the,IHI event, to introduce its LifeGurney system, ...
... prostate cancer patients with drugs that block hormonal activity ... from cardiovascular disease, according to a study led by ... report from members of the same study team found ... risk of diabetes and heart disease, the current study ...
... A group of nutritionists from Extenso, the Universit de ... chefs from the Institut de tourisme et d,htellerie du ... and early childhood centres. The goal is to help ... for kids. , The nutrition team will provide its ...
... Ga., Dec. 10 Joe Jurevicius, Tom Brady, ... few months the list,of top professional football players ... read as a who,s who of the National ... infections is healthcare facilities,where athletes are undergoing surgeries, ...
Cached Medicine News:Health News:Obesity among state's low-income teens nearly triple that of more affluent peers 2Health News:ThermoGenesis Introduces New Cell Separation Technology for Veterinary Use at Major Equine Convention 2Health News:ThermoGenesis Introduces New Cell Separation Technology for Veterinary Use at Major Equine Convention 3Health News:ThermoGenesis Introduces New Cell Separation Technology for Veterinary Use at Major Equine Convention 4Health News:Hoana Medical to Present at the National Forum on Quality Improvement in Health Care 2Health News:Hoana Medical to Present at the National Forum on Quality Improvement in Health Care 3Health News:Hoana Medical to Present at the National Forum on Quality Improvement in Health Care 4Health News:Hormone therapy for prostate cancer does not appear to increase cardiac deaths 2Health News:Hormone therapy for prostate cancer does not appear to increase cardiac deaths 3Health News:New partnership to foster healthier food habits in early childhood 2Health News:Staph Infections Hit Professional Football Hard 2Health News:Staph Infections Hit Professional Football Hard 3
Pocket-sized instrument with direct illumination. Avaliable in black, green or blue....
Provides 30% more illumination, high light output for true tissue. Wide-angle viewing lens, sealed system for pneumatic otoscopy....
Provides 30% more magnification and twice the field of view. Adjustable focus, with insufflator bulb....
... delivers power and reliability with proprietary ... Diode side-pumping technology drives 2.5 W ... Spectra system, and active resonator temperature ... system reliability from your first treatment ...
Medicine Products: